Legal Representation
Attorney
Margaret A. Boulware
USPTO Deadlines
Next Deadline
2945 days remaining
Section 8 & 9 (30-Year) Renewal Due (Based on registration date 2003-08-05)
Due Date
August 05, 2033
Grace Period Ends
February 05, 2034
Application History
21 events| Date | Code | Type | Description |
|---|---|---|---|
| Nov 3, 2023 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Nov 3, 2023 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
| Nov 3, 2023 | RNL2 | Q | REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) |
| Nov 3, 2023 | NA89 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
| May 10, 2023 | E89R | I | TEAS SECTION 8 & 9 RECEIVED |
| Jul 8, 2013 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Jul 8, 2013 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
| Jul 8, 2013 | RNL1 | Q | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
| Jul 8, 2013 | NA89 | O | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - MAILED |
| Jun 27, 2013 | E89R | I | TEAS SECTION 8 & 9 RECEIVED |
| Sep 15, 2010 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Jul 28, 2009 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| Jul 20, 2009 | PLGL | A | ASSIGNED TO PARALEGAL |
| Jul 13, 2009 | E815 | I | TEAS SECTION 8 & 15 RECEIVED |
| Mar 4, 2009 | CFIT | O | CASE FILE IN TICRS |
| Aug 5, 2003 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| May 13, 2003 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Apr 23, 2003 | NPUB | O | NOTICE OF PUBLICATION |
| Mar 2, 2003 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Feb 24, 2003 | CNEA | F | EXAMINER'S AMENDMENT MAILED |
| Feb 14, 2003 | DOCK | D | ASSIGNED TO EXAMINER |
Detailed Classifications
Class 044
Discount health care program in the fields of prescription drugs
First Use Anywhere:
Jun 15, 2002
First Use in Commerce:
Jun 15, 2002
Additional Information
Pseudo Mark
TEAM STAR RX
Classification
International Classes
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"RX"
USPTO Documents
Loading USPTO documents...